Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-06-06
1998-03-10
Richter, Johann
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
549354, 549 12, 549 13, 549458, 546 89, 546 80, 546 93, 568326, C07D31302, C07D33380
Patent
active
057263256
DESCRIPTION:
BRIEF SUMMARY
This application is a 371 of PCT/JP96/02997 filed Oct. 16, 1996.
TECHNICAL FIELD
The present invention relates to tricyclic compounds which are useful as therapeutic agents for urinary incontinence.
BACKGROUND ART
Japanese Published Unexamined Patent Application No. 286915/93 discloses N-substituted propanamide derivatives which are useful for the treatment of urinary incontinence.
DISCLOSURE OF THE INVENTION
The present invention relates to tricyclic compounds represented by general formula (I): ##STR2## wherein R.sup.1 represents hydrogen, lower alkyl, lower alkoxy, or halogen; --X.sup.1 --X.sup.2 --X.sup.3 -- represents --CR.sup.2 .dbd.CR.sup.3 --CR.sup.4 .dbd.CR.sup.5 -- (wherein R.sup.2, R.sup.3, R.sup.4, and R.sup.5, which may be the same or different, each represents hydrogen, lower alkyl, lower alkoxy, or halogen), --CR.sup.2 .dbd.CR.sup.3 --CR.sup.4 .dbd.N-- (wherein R.sup.2, R.sup.3, and R.sup.4 have the same significances as defined above), --CR.sup.2 .dbd.CR.sup.3 --S-- (wherein R.sup.2 and R.sup.3 have the same significances as defined above), --CR.sup.2 .dbd.CR.sup.3 --O-- (wherein R.sup.2 and R.sup.3 have the same significances as defined above), --S--CR.sup.4 .dbd.CR.sup.5 -- (wherein R.sup.4 and R.sup.5 have the same significances as defined above), or --O--CR.sup.4 .dbd.CR.sup.5 -- (wherein R.sup.4 and R.sup.5 have the same significances as defined above); and Y represents --CH.sub.2 O--, --CH.sub.2 S--, --CH.sub.2 SO--, --CH.dbd.CH--, or --(CH.sub.2).sub.n -- Compound (I), and the same applies to the compounds of other formula numbers!.
In the definitions of the groups in general formula (I), the lower alkyl and the lower alkyl moiety of the lower alkoxy mean a straight-chain or branched alkyl group having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, and hexyl. The halogen includes fluorine, chlorine, bromine, and iodine.
The processes for preparing Compound (I) are described below.
Compound (I) can be prepared according to the following reaction step. ##STR3## (In the formulae, R.sup.1, --X.sup.1 --X.sup.2 --X.sup.3 --, and Y have the same significances as defined above.)
Compound (I) can be obtained by treating Compound (II) with an equivalent amount of halogenating agent such as thionyl chloride and oxalyl chloride in an inert solvent such as dichloromethane, dichloroethane, tetrachloroethane and dimethylacetamide at -30.degree. to 0.degree. C. for 5 minutes to 12 hours, and then subjecting the obtained substance to reaction with Compound (III) at a temperature between 0.degree. C. and the boiling point of the solvent used for 5 minutes to 24 hours. This reaction is preferably carried out under an atmosphere of dry inert gas such as argon gas and nitrogen gas.
The starting Compound (II) can be obtained according to the process described in J. Chem. Soc., 2329-2332 (1951). The starting Compound (III) may be commercially available, or can be prepared according to the processes described in the following Steps 2 through 4.
Compound (III) can be prepared according to the following reaction steps. ##STR4## (In the formulae, R.sup.1, --X.sup.1 --X.sup.2 --X.sup.3 --, and Y have the same significances as defined above.)
The starting Compound (IV) can be obtained according to the known methods (1977); ibid., 20, 1557 (1977); ibid., 21, 633 (1978); ibid., 22, 1357 (1979); ibid., 27, 372 (1984); ibid., 29, 2347 (1986); ibid., 29, 2074 (1992); ibid., 38, 496 (1995), etc.! or similar methods thereto.
Compound (V) can be obtained by treating Compound (IV) according to the methods described in Synthesis, 295 (1990), etc. in tert-butanol in the presence of an equivalent amount of diphenylphosphoryl azide under an atmosphere of dry inert gas such as argon gas and nitrogen gas.
Compound (III) can be obtained by hydrolyzing Compound (V) in an appropriate solvent such as trifluoroacetic acid, hydrochloric acid/dioxane and hydrobromic acid/acetic acid at a temperature between 0.degree. C. and the boiling point of the solvent used
REFERENCES:
patent: 4477465 (1984-10-01), Martin et al.
patent: 5116863 (1992-05-01), Oshima et al.
patent: 5272163 (1993-12-01), Russell et al.
J. Med. Chem., vol. 39, No. 23 (Nov. 1996) pp. 4592-4601.
Aono Shigeru
Fujiwara Shigeki
Karasawa Akira
Nagashima Ken
Sasaki Shin-ichi
Kyowa Hakko Kogyo Co. Ltd.
Richter Johann
Stockton Laura L.
LandOfFree
Tricyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-141002